Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Saladax Biomedical Inc.
DescriptionBlood test used to measure and help optimize a patient's exposure to paclitaxel therapy
Molecular Target
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationCancer, Diagnostic
Indication DetailsIdentify paclitaxel-treated patients who are at high risk of severe toxicity by measuring their systemic drug exposure
Regulatory Designation
PartnerShanghai Fosun Pharmaceutical Group Co. Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today